Arcturus Therapeutics
Develops mRNA medicines for rare diseases and a CSL-partnered COVID-19 vaccine.
$15.10
After-hours close−0.09 (−0.59%)
At close$15.19(−6.06%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.67 | — | — |
| Aug 2026 | −$1.00 | −$0.84 | +15.7% |
| May 2026 | −$1.03 | −$0.95 | +7.9% |
| Mar 2026 | −$0.92 | −$1.03 | −12.0% |
| Nov 2025 | −$0.80 | −$0.49 | +38.7% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Oct 2018 | |||
| May 2018 | |||
| Apr 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Feb 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Feb 2016 | |||
| Nov 2015 | |||
| Aug 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 9, 2026 | −$0.67 | — | — | $8.0M | — | — |
| Aug 6, 2026 | −$1.00 | −$0.84 | +15.7% | $3.1M | $3.0M | −4.8% |
| May 7, 2026 | −$1.03 | −$0.95 | +7.9% | $6.3M | $2.1M | −67.3% |
| Mar 3, 2026 | −$0.92 | −$1.03 | −12.0% | $15.9M | $7.2M | −54.7% |
| Nov 10, 2025 | −$0.80 | −$0.49 | +38.7% | $16.0M | $17.2M | +7.0% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | ||||||
| Aug 11, 2025 | ||||||
| May 12, 2025 | ||||||
| Mar 6, 2025 | ||||||
| Nov 7, 2024 | ||||||
| Aug 5, 2024 | ||||||
| May 8, 2024 | ||||||
| Mar 7, 2024 | ||||||
| Nov 14, 2023 | ||||||
| Aug 7, 2023 | ||||||
| May 9, 2023 | ||||||
| Mar 28, 2023 | ||||||
| Nov 9, 2022 | ||||||
| Aug 9, 2022 | ||||||
| May 9, 2022 | ||||||
| Feb 28, 2022 | ||||||
| Nov 8, 2021 | ||||||
| Aug 9, 2021 | ||||||
| May 10, 2021 | ||||||
| Mar 1, 2021 | ||||||
| Nov 9, 2020 | ||||||
| Aug 10, 2020 | ||||||
| May 7, 2020 | ||||||
| Mar 11, 2020 | ||||||
| Nov 7, 2019 | ||||||
| Aug 15, 2019 | ||||||
| May 13, 2019 | ||||||
| Mar 18, 2019 | ||||||
| Nov 7, 2018 | ||||||
| Oct 1, 2018 | ||||||
| May 14, 2018 | ||||||
| Apr 2, 2018 | ||||||
| Nov 9, 2017 | ||||||
| Aug 11, 2017 | ||||||
| May 30, 2017 | ||||||
| Feb 15, 2017 | ||||||
| Nov 15, 2016 | ||||||
| Aug 30, 2016 | ||||||
| May 16, 2016 | ||||||
| Feb 17, 2016 | ||||||
| Nov 12, 2015 | ||||||
| Aug 13, 2015 | ||||||